Port Huron, Michigan Clinical Trials

A listing of Port Huron, Michigan clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Study to Assess the Efficacy Safety and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Study of the efficacy, safety, tolerability, pharmacokinetics (PK), and immunogenicity of Vixarelimab (KPL-716) in subjects with prurigo nodularis.

prurigo
Site 113
 (6.6 away) Contact site
  • 129 views
  • 16 May, 2021
  • +60 other locations
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

Patients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive disease features will receive salvage radiation therapy and standard androgen deprivation therapy (ADT) or enhanced ADT to determine if there is any improvement in progression-free survival when enhanced ADT is used compared to standard ADT.

bicalutamide
recurrent prostate cancer
prostatectomy
antiandrogen therapy
growth factor
McLaren Cancer Institute - Port Huron
 (1.4 away) Contact site
  • 118 views
  • 16 Jun, 2021
  • +102 other locations
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

This phase II Lung-MAP non-Match treatment trial studies how well ramucirumab and pembrolizumab work versus standard of care in treating patients with non-small cell lung cancer that is stage IV or has come back. Immunotherapy with monoclonal antibodies, such as ramucirumab and pembrolizumab, may help the body's immune system attack …

metastasis
line of therapy
unstable angina
ascites
cardiac disease
Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 80 views
  • 25 Jan, 2021
  • +628 other locations
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

This phase II trial studies how pembrolizumab works before and after surgery in treating patients with stage III-IV high-risk melanoma. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.. Giving …

Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 71 views
  • 16 Jun, 2021
  • +685 other locations
Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Open-label, long-term safety study of ARQ-154 foam 0.3% in subjects with seborrheic dermatitis involving up to 20% total Body Surface Area (BSA). Study medication will be applied by the qualifying subjects topically once daily for 52 weeks. Cohort 1 subjects are rollover subjects from a prior ARQ-154 trial. Cohort 2 …

erythema
Arcutis Biotherapeutics Clinical Site 58
 (7.6 away) Contact site
  • 7 views
  • 06 May, 2021
  • +35 other locations
Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

This phase II trial studies how a diet intervention works in improving bowel dysfunction symptoms related in colon or rectal cancer survivors. Changing a diet may be helpful in reducing the severity of bowel symptoms, including diarrhea and constipation, and improve quality of life in colon or rectal cancer survivors …

low anterior resection
inflammatory bowel disease
cancer
constipation
rectal carcinoma
Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 0 views
  • 19 May, 2021
  • +231 other locations
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

This phase II Lung-MAP trial studies how well rucaparib works in treating patients with genomic loss of heterozygosity (LOH) high and/or deleterious BRCA1/2 mutation stage IV non-small cell lung cancer or that has come back. Rucaparib may stop the growth of tumor cells by blocking some of the enzymes needed …

skin cancer
metastasis
line of therapy
unstable angina
ascites
Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 175 views
  • 09 May, 2021
  • +746 other locations
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer the DECREASE Study

This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing …

McLaren-Port Huron
 (1.4 away) Contact site
  • 11 views
  • 13 Mar, 2021
  • +353 other locations
To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

To evaluate the efficacy and safety of INCB054707 in participants with hidradenitis suppurativa over a 16-week placebo-controlled treatment period followed by a 36 -week open-label extension period.

antiseptics
hidradenitis
Investigative Site 004
 (7.6 away) Contact site
  • 35 views
  • 16 Jun, 2021
  • +24 other locations
A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

The purpose of this study is to assess the effect of nemolizumab (CD14152) on humoral immune responses to tetanus and meningococcal vaccination in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD).

atopy
nemolizumab
vaccination
Galderma Investigational Site
 (7.6 away) Contact site
  • 208 views
  • 27 Jan, 2021
  • +112 other locations